Clinical Trial Update: Allogenic Transplantation of Ex-vivo Expanded Cord Blood (CB) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating allogeneic cord blood transplantation with ex vivo expansion was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematological Malignancies

Snippet

Sponsor: Dr. Avichai Shimoni MD | Conditions: Umbilical Cord Blood, Stem Cell Transplantation | Phase 1 | Status: WITHDRAWN